Pandemic Perspectives: US FDA Wastes No Time In COVID-19 Emergency Use Authorization Reviews

 
• By Sue Sutter
Hand Holding Syringe, Vaccine Injection, Virus Background, Prevention of Covid-19, Coronavirus Disease
The FDA's average review time for COVID-19 vaccine EUAs is 22 days. • Source: Shutterstock

More from Review Pathways

More from Pathways & Standards